Overcoming quality inspection challenges: Complete set of famotidine impurities available

  Famotidine is a third-generation, highly effective H2 receptor antagonist primarily used to inhibit gastric acid secretion, treating conditions such as gastric and duodenal ulcers, and gastroesophageal reflux disease (GERD).

  By selectively antagonizing the H2 receptors on gastric parietal cells, famotidine potently inhibits basal, nocturnal, and stimulated (e.g., by histamine or gastrin) gastric acid secretion. Its potency is approximately 20 times greater than that of the earlier-generation drug cimetidine. Due to its prolonged acid-suppressing effect and favorable safety profile, it has become a cornerstone medication in the clinical prevention and treatment of gastric/duodenal ulcers, GERD, and acute gastric mucosal bleeding, among other conditions.

  The impurity profile of famotidine is complex, and its research and control represent one of the most challenging aspects of drug quality assurance. During the synthesis of famotidine, changes in its core thiazole-guanidine and thioether side-chain structures can occur. While it is relatively stable under light, it is prone to degradation under acidic, alkaline, oxidative, and heated conditions, generating multiple unknown degradation products. Various impurities can also be introduced during manufacturing and storage.

  Pharmacopoeias worldwide have clear requirements for system suitability in impurity testing (e.g., resolution, theoretical plate number). Analytical methods must undergo comprehensive validation to ensure specificity, sensitivity, precision, and robustness, meeting the review standards of global regulatory agencies.

  SZEB supplies a complete set of famotidine impurity reference standards readily available, including Famotidine EP Impurities, Famotidine Oxidation Products, Famotidine Dimers/Polymers, etc. Each comes with comprehensive technical documentation, including Certificates of Analysis , structural confirmation spectra, and analytical methods. Find a wider range of complete related impurity reference standards for various new drugs and key generic drugs on our official website. Contact us by sales@ec-biotech.cn .